Accelrys' Electronic Laboratory Notebooks Recognized in Gartner's Enterprise Category

Wed Jan 30, 2013 7:30am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link

Breadth of ELNs rated Very High or High in Each Scientific and Functional Domain
SAN DIEGO,  Jan. 30, 2013  /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a
leading provider of scientific innovation lifecycle management software, today
announced that Gartner, IncĀ­., the leading provider of research and analysis on
the global information technology industry, has rated the company's electronic
laboratory notebooks (ELN) as "very high" or "high" in each scientific and
functional domain in a recent report on considerations for selecting an ELN.
Accelrys was the only vendor with ELNs that achieved those ratings in all


The report, published  Jan. 11, 2013  and titled "Manufacturers Must Consider
Scientific Domain Expertise During ELN Selection," is based on insights
collected by Gartner throughout hundreds of interviews, briefings and
interactions with various clients. The Accelrys ELN secured a "very high" rating
in chemistry, meaning the product is close to becoming a de facto standard in
that category, as well as "high" ratings in biology, formulation, engineering,
regulated environments and translational medicine. The Accelrys Laboratory
Execution System was rated  "very high" in regulated environments and "high" in
formulation, while the Contur ELN rated "high" in chemistry.  

"In the push to reduce innovation cycle times and share information among
scientists and engineers, ELN technologies have the potential to be valuable
tools, especially for transferring knowledge from ideas into product
development," Gartner research director  Michael Shanler  said in the report.
"However, as companies move toward "end-to-end" informatics solutions that
extend from research into manufacturing, deep scientific functionality is often
compromised when moving toward single solution providers. While IT often weights
value for lower cost, simple governance and architecture simplicity, R&D sees
deep scientific functionality as the primary criterion for sustaining

"With deep scientific domain experience and an integrated set of solutions for
optimizing the lab-to-commercialization value chain - from research through
downstream analytical development, quality control, quality assurance and
manufacturing - Accelrys is proving that neither functionality nor expertise
should be compromised in the quest to improve innovation," said Accelrys
President and CEO  Max Carnecchia. "We believe Gartner's 'high' and 'very high'
ratings of our ELNs confirm our industry leading position in the market and our
ability to deliver a breadth of solutions across scientific and functional
domains for a diverse and global customer base."

About Accelrys, Inc.
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation
lifecycle management software, supports industries and organizations that rely
on scientific innovation to differentiate themselves. The industry-leading
Accelrys Enterprise Platform provides a broad and flexible scientific solution
optimized to integrate the diversity of science, experimental processes and
information requirements across the research, development, process scale-up and
early manufacturing phases of product development. By incorporating capabilities
in applications for modeling and simulation, enterprise lab management, workflow
and automation, and data management and informatics, Accelrys enables scientific
innovators to access, organize, analyze and share data in unprecedented ways,
ultimately enhancing innovation, improving productivity and compliance, reducing
costs and speeding time from lab to market.

Accelrys solutions are used by more than 1,300 companies in the pharmaceutical,
biotechnology, energy, chemicals, aerospace, consumer packaged goods and
industrial products industries. Headquartered in  San Diego, California, USA,
Accelrys employs more than 200 full-time PhD scientists. For more information
about Accelrys, visit  

SOURCE  Accelrys, Inc.

Racepoint Group For Accelrys, Marla Kertzman, +1-415-694-6701,

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.